Cargando…
GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting
BACKGROUND: To evaluate the benefits of teduglutide in a real-life setting, we analyzed the data of 14 patients with short bowel syndrome treated with teduglutide. Additionally, we studied glucagon-like peptide 2 (GLP-2) receptor expression in samples of small intestinal and colonic tissue to provid...
Autores principales: | Schoeler, Marc, Klag, Thomas, Wendler, Judith, Bernhard, Simon, Adolph, Michael, Kirschniak, Andreas, Goetz, Martin, Malek, Nisar, Wehkamp, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196620/ https://www.ncbi.nlm.nih.gov/pubmed/30364471 http://dx.doi.org/10.1177/1756284818793343 |
Ejemplares similares
-
Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria
por: Saman, Sadik, et al.
Publicado: (2019) -
Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support
por: Chiba, Masahiro, et al.
Publicado: (2023) -
Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease
por: Niepel, Dorothea, et al.
Publicado: (2018) -
Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials
por: Seidner, Douglas L., et al.
Publicado: (2019) -
Case Report: Morphologic and Functional Characteristics of Intestinal Mucosa in a Child With Short Bowel Syndrome After Treatment With Teduglutide: Evidence in Favor of GLP-2 Analog Safety
por: Falco, Enrico Costantino, et al.
Publicado: (2022)